/wp-content/uploads/logo-1.png 0 0 CURC /wp-content/uploads/logo-1.png CURC2015-04-23 15:20:452015-04-23 15:20:45consensus-controversy-thumb
Blog - Latest News
You are here: Home1 / A new endocrine therapy paradigm in metastatic prostate cancer2 / consensus-controversy-thumb
- Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial
- Understanding the Underutilization of Germline Genetic Testing in Prostate Cancer
- Dr. Shore Presents Practice-Changing Data In Prostate Cancer / EMBARK points to potential new standard of care for high-risk BCR.
- AUA Chicago April 28 – May 1, 2023- Here We Come